A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation

Br J Haematol. 2018 Nov;183(4):664-668. doi: 10.1111/bjh.15002. Epub 2017 Dec 22.
No abstract available

Keywords: autologous stem cell transplantation; droplet digital PCR; minimal residual disease; multiple myeloma; next-generation sequencing.

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Autografts
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma* / blood
  • Multiple Myeloma* / genetics
  • Multiple Myeloma* / therapy
  • Neoplasm, Residual
  • Real-Time Polymerase Chain Reaction*
  • Transplantation, Autologous